UPPER RESPIRATORY DISEASE
Clinical trials for UPPER RESPIRATORY DISEASE explained in plain language.
Never miss a new study
Get alerted when new UPPER RESPIRATORY DISEASE trials appear
Sign up with your email to follow new studies for UPPER RESPIRATORY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cold virus drug prevent COPD Flare-Ups?
Disease control CompletedThis study tested whether the drug vapendavir can reduce breathing problems in people with COPD who catch a rhinovirus (common cold). Fifty-two adults with COPD were given either vapendavir or a placebo after being exposed to the virus. The main goal was to see if vapendavir lowe…
Matched conditions: UPPER RESPIRATORY DISEASE
Phase: PHASE2 • Sponsor: Altesa Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Head-to-Head: which COVID booster works better?
Prevention CompletedThis study tested how well two different 2023-2024 updated COVID-19 vaccines (Novavax and Pfizer mRNA) protect adults from getting sick with COVID-19. About 1,200 adults who had already received at least two mRNA vaccine doses were randomly assigned to get either the Novavax or P…
Matched conditions: UPPER RESPIRATORY DISEASE
Phase: PHASE4 • Sponsor: Sarang K. Yoon, DO, MOH • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC